Navigation Links
Frost & Sullivan Hosts Presentation on MicroRNAs: From Stem Cells and Cancer to Diagnostics and Therapeutics
Date:3/30/2009

A Complimentary Webinar

MOUNTAIN VIEW, Calif., March 30 /PRNewswire/ --

     -  TOPIC:      The state of the microRNA market and the molecule's
                    current and potential impact on drug discovery, molecular
                    diagnostics, and personalized therapeutics.
     -  WHEN:       Tuesday, March 31, 2009
     -  TIME:       3 pm EDT
     -  LOCATION:   Online with free registration
     -  HOST:       Christi Bird, Senior Research Analyst, Healthcare
                    practice, Frost & Sullivan
     -  GUESTS:
          -  Dr. George Calin, Associate Professor, The University of Texas
             M. D. Anderson Cancer Center
          -  Alex Amiet, Senior Product Manager, Thermo Fisher Scientific


     -  This panel discussion will benefit life science research tools
        manufacturers, services providers, diagnostic companies,
        biotechnology companies, pharmaceutical companies, academic
        researchers and venture capitalists.  The outlook for the microRNA
        market will be presented from a three-pronged perspective of an
        industry analyst with knowledge of the market, a microRNA expert
        from academia, and a provider of microRNA tools and services.

Supporting Quote

"The rapid discoveries linking microRNAs to various diseases have propelled the microRNA field and tools market in recent years. Moving forward, however, the microRNA field requires more innovative studies of larger scope to make good on its lofty promise," says Bird of Frost & Sullivan.

Supporting Resources

To participate, please email Stephanie Ochoa, stephanie.ochoa@frost.com, with the following information: your full name, title, company name, company telephone number, company email address, city, state and country. Upon receipt of the above information, a registration link will be emailed to you. You may also register to receive a recorded version of the briefing at anytime by submitting the aforementioned contact details.

Frost & Sullivan's Drug Discovery practice: www.frost.com/drugdiscovery

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 31 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.

    Contact:
    Stephanie Ochoa
    Frost & Sullivan
    +1.210.247.2421
    stephanie.ochoa@frost.com

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)


'/>"/>
SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Frost & Sullivan Award Highlights Opportunity for Main Street Biotech
2. Frost & Sullivan Recognizes Life Technologies for Excellence in the Life Science Research Tools Industry
3. Frost & Sullivan Recognizes Excellence in Medical Technologies & Life Sciences
4. Frost & Sullivan Recognizes Nanopoint for its Pioneering Cell Imaging Solution, the cellTRAY(R) Imaging System CT-2000
5. Frost & Sullivan: In Vitro Diagnostics Market
6. Frost & Sullivan Recognizes Novagali Pharma for Innovation in Ophthalmic Therapies
7. Frost & Sullivan European Drug Discovery Product Innovation Award Bestowed on Xenometrix AG
8. Frost & Sullivan Recognizes ApaTechs Leadership in Orthopedic Biologics
9. The Need for Safe and Affordable Biopharmaceuticals Drives the Development of the European Biosimilars Market, Says Frost & Sullivan
10. Magellan to Receive Frost & Sullivan 2009 North American Product Innovation Award; Three-Minute LeadCare(R) II Test Identifies Children with Lead Poisoning
11. Frost & Sullivan to Present the 2009 Excellence in Medical Technologies & Life Sciences Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... 2016  Vermillion, Inc. (NASDAQ: VRML ), a ... the formation of the Steering Committee for its Pelvic ... --> Pelvic masses can present physicians and healthcare ... pregnancy is ruled out, pelvic masses may include cancers ... benign ovarian tumors and gastrointestinal and urinary tract masses. ...
(Date:2/11/2016)... , Germany and ... QGEN ; Frankfurt Prime Standard: QIA) today ... Targeted RNA Panels for gene expression profiling, expanding QIAGEN,s ... (NGS). The panels enable researchers to select from over ... changes and discover interactions between genes, cellular phenotypes and ...
(Date:2/11/2016)... , Feb. 11, 2016  Bioethics International, a not-for-profit organization ... researched, developed, marketed and made accessible to patients around the ... had named the publication of the Good Pharma ... publication is also featured as one of BMJ Open ... last year that are most frequently read. Ed ...
(Date:2/11/2016)... 2016  Spectra BioPharma Selling Solutions (Spectra) is ... biopharma companies the experience, expertise, operational delivery and ... sales teams. Created in concert with industry leading ... strategic and tactical needs of its clients by ... both personal and non-personal promotion. ...
Breaking Biology Technology:
(Date:2/9/2016)... Aware, Inc. (NASDAQ: AWRE ), a leading supplier of biometrics ... and year ended December 31, 2015.  --> ... was $6.9 million, an increase of 61% compared to $4.3 million ... quarter of 2015 was $2.6 million compared to $0.2 million in ... --> Higher revenue and operating income in the fourth ...
(Date:2/5/2016)... Feb. 5, 2016 ... the "Global Facial Recognition Market 2016-2020" ... http://www.researchandmarkets.com/research/5kvw8m/global_facial ) has announced the addition ... 2016-2020" report to their offering. ... ) has announced the addition of the ...
(Date:2/3/2016)... India , February 3, 2016 ... the new market research report "Automated Fingerprint Identification System ... Search, Latent Search), Application (Banking & Finance, Government, Healthcare, ... published by MarketsandMarkets, the market is expected to be ... CAGR of 21.0% between 2015 and 2020. The transformation ...
Breaking Biology News(10 mins):